Epic Sciences

12.07.2018 / Portland / San Diego Back to News Listings

Video - Genomic Sequencing: Precision data to better fight advanced cancer

Bryce Olson and KATU2 News (Portland, Oregon) discuss the importance of personalized medicine, including the Oncotype DX® AR-V7 Nucleus Detect™ test, in aiding pivotal metastatic castration-resistant prostate cancer treatment decisions. The test, developed by Epic Sciences and commercially available through Genomic Health, is now covered by Medicare. 

Originally posted on KATU2 News.